Energy Transfer: Less Attractive For Fresh Buyers (Archive) Valuation discounts have narrowed and technicals point to fading upside for incremental buyers.
Why NVIDIA Is Not Yet In Its Hype Cycle (Archive) NVIDIA is growing in multiples, margins are soaring, and valuations still avoid true hype.
Super Micro Computer: The Time Correction Is Not Yet Over (Archive) SMCI’s stellar AI-driven growth persists, but margins, ROICs, and valuation temper conviction.
Pfizer: Too Early For A Turnaround (Archive) Pfizer’s oncology pivot and CEO incentives cloud the timing and quality of any turnaround.
Palantir: Insider Sales And High Valuations Vs. Strong Operational Performance (Archive) Palantir’s strong execution contrasts with heavy insider selling and stretched valuations.
Microsoft: Superior Focus On Azure And ARPU Growth To Drive Outperformance (Archive) Azure’s accelerating momentum, ARPU gains, and technicals position Microsoft for sustained outperformance.
Berkshire Hathaway: Why I Still Think It Will Likely Underperform The Market (Archive) Apple concentration, manufacturing weakness and fair-value valuation point to negative alpha ahead.